4.8 Article

Peli1 negatively regulates noncanonical NF-κB signaling to restrain systemic lupus erythematosus

Journal

NATURE COMMUNICATIONS
Volume 9, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-018-03530-3

Keywords

-

Funding

  1. National Natural Science Foundation of China [81571545, 81770567]
  2. Jiangsu Provincial Key and Development Program [BE2016722]
  3. Thousand Young Talents Plan of China
  4. US National Institutes of Health [AI104519]
  5. CAS Key Laboratory of Stem Cell Biology
  6. Collaborative Innovation Center of Systems Biomedicine

Ask authors/readers for more resources

Systemic lupus erythematosus (SLE) is characterized by uncontrolled secretion of auto-antibodies by plasma cells. Although the functional importance of plasma cells and auto-antibodies in SLE has been well established, the underlying molecular mechanisms of controlling autoantibody production remain poorly understood. Here we show that Peli1 has a B cell-intrinsic function to protect against lupus-like autoimmunity in mice. Peli1 deficiency in B cells induces autoantibody production via noncanonical NF-kappa B signaling. Mechanically, Peli1 functions as an E3 ligase to associate with NF-kappa B inducing kinase (NIK) and mediates NIK Lys48 ubiquitination and degradation. Overexpression of Peli1 inhibits noncanonical NF-kappa B activation and alleviates lupus-like disease. In humans, PELI1 levels negatively correlate with disease severity in SLE patients. Our findings establish Peli1 as a negative regulator of the noncanonical NF-kappa B pathway in the context of restraining the pathogenesis of lupus-like disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available